Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 1 Jul 22 424B5 Prospectus supplement for primary offering
- 29 Jun 22 424B5 Prospectus supplement for primary offering
- 23 Mar 21 424B5 Prospectus supplement for primary offering
- 22 Mar 21 424B5 Prospectus supplement for primary offering
- 26 Mar 20 EFFECT Notice of effectiveness
-
13 Mar 20 S-3 Shelf registration
VRCA similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Verrica Pharmaceuticals Inc.:
We consent to the use of our report incorporated by reference herein and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP | ||||
Philadelphia, Pennsylvania | ||||
March 13, 2020 |